Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
XTalks
NOVEMBER 3, 2022
Since its US approval in June of last year, demand for Novo’s weight loss drug Wegovy has been skyrocketing, and with a recent informal endorsement from Elon Musk on Twitter , demand is only expected to further increase. Related: Mounjaro (tirzepatide), Eli Lilly’s Highly Awaited Type 2 Diabetes Injection Gets FDA Nod.
Let's personalize your content